Willow vs Embody: Oral GLP-1 with Coaching vs Low-Cost Compounded Care
Willow vs Embody compares a telehealth-first, oral GLP-1 program focused on progress tracking and follow-up (Willow) with a low-cost, fast-shipping compounded GLP-1 option (Embody). Early verdict: choose Willow if you want structured digital follow-up and coaching; choose Embody if your priority is the lowest entry price and rapid home delivery.
Explore Willow’s structured oral GLP-1 program
Quick direct comparison: what sets them apart
This comparison focuses on the clearest differences supported by the sources: price and pricing model, program features and support, medication format and regulatory notes, shipping and delivery speed, and ideal customer fit. Willow emphasizes an oral GLP-1 journey with progress tracking and follow-up consultations. Embody emphasizes low monthly pricing for compounded semaglutide and fast 1–2 day shipping after approval.
1. Price and pricing model
Willow lists a starting price of 299. Embody advertises compounded semaglutide at $69/month, reduced from $299, and compounded tirzepatide at $119/month. Embody positions $69 as a limited-time entry price and says final pricing may vary slightly based on dose and clinician recommendation.
See Embody’s $69/month semaglutide offer
2. Program features and clinical follow-up
Willow is described as a telehealth-first weight management program that frames oral GLP-1 as part of a structured journey, with licensed telehealth team support, progress tracking tools, and follow-up consultations. Embody offers telemed visits and licensed provider review but emphasizes a no-frills, prescription-forward model with fewer premium features and no integrated coaching or advanced monitoring noted.
View Willow’s follow-up and tracking features
3. Medication format and regulatory notes
Willow presents an oral GLP-1 program; it also notes that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Embody provides compounded semaglutide and compounded tirzepatide and includes the regulatory note that compounded medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness or quality.
4. Shipping, delivery, and commitments
Embody explicitly advertises free shipping and delivery in 1–2 days after clinician approval, no monthly membership, and the ability to cancel anytime. Willow’s captured page did not verify shipping, fees, membership, or cancellation details in the evidence provided.
| Criteria | Willow | Embody |
|---|---|---|
| Starting price | $299 starting | $69/month semaglutide; $119/month tirzepatide |
| Program focus | Oral GLP-1 with progress tracking and follow-up | Compounded GLP-1, low-cost prescription delivery |
| Support features | Licensed telehealth team, tracking tools, follow-up consultations | Telemed visits and licensed provider review; fewer premium features |
| Medication type | Oral GLP-1 program; compounded meds noted as not FDA-approved when offered | Compounded semaglutide and tirzepatide; compounded meds not FDA-approved |
| Shipping and commitment | Not verified on captured page | Free 1–2 day shipping after approval; no monthly membership; cancel anytime |
How these differences affect your choice
Willow frames care as a structured weight management journey where tracking and clinician follow-up are central. That may matter for patients who want behavioral support alongside medication. Embody emphasizes affordability and fast delivery for patients seeking the lowest entry price and quick home delivery, accepting fewer premium features in exchange for lower cost.
Safety and regulatory context
Both sources include explicit regulatory notes about compounded medications not being FDA-approved finished products, and Willow notes treatment is available only when a licensed clinician determines it is medically appropriate. Embody states prescriptions follow licensed clinician review and medications are filled at a licensed pharmacy, with the same regulatory qualifier about compounded products.
Check Embody’s prescription process and shipping
Conclusion: Choose Willow vs Embody
Willow vs Embody is a straight trade-off between structured digital follow-up and coaching versus low-cost, fast-delivery compounded care. Choose Willow if you want an oral GLP-1 program built around progress tracking and follow-up consultations with a licensed telehealth team. Choose Embody if your priority is the lowest entry price for compounded semaglutide or tirzepatide and fast, free 1–2 day shipping after clinician approval.